WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it will be an active participant at the Connected Health Symposium on October 20-21 in Boston sponsored by Partners Healthcare. Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix, will be a panelist for a discussion entitled: “New Wearables for Health and Wellness: Monitoring and Therapy.” In addition, NeuroMetrix will present a scientific poster entitled: “Sleep Phenotypes in Chronic Pain Suffers: Application of Machine Learning to a Large Database.” The Company will sponsor an exhibition providing information and demonstrations of its Quell® wearable technology for chronic pain at booth 132 at the Symposium.
"We are pleased to participate in the discussion about the role that health monitoring and therapeutic technologies are playing in reshaping healthcare,” said Dr. Gozani. “With over 30,000 Quell devices in the market and 2 million hours of patient data in the Quell Health Cloud, we are uncovering important trends related to sleep and the management of chronic pain.”
Quell is designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can start, stop, and adjust therapy discreetly via the optional Quell Relief app. Quell also offers advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. Quell is available at select healthcare professionals and retailers. Visit QuellRelief.com for more information.
About Partners Healthcare and Partners Connected Health
Partners Healthcare is a not-for-profit health care system that is committed to patient care, research, teaching, and service to the community locally and globally. Partners HealthCare Connected Health creates and validates technology-enabled solutions that empower patients and providers to transform health care. From ideation to research to program design and implementation, a multi-disciplinary team develops innovations that facilitate collaborative care, self-management, and improved quality. Partners collaborates with providers, patients, policy makers and industry to demonstrate the power of technology-enabled interventions in research studies and in “real-world” clinical and remote patient settings. The interventions designed and developed by Partners Connected Health focus on creating behavior change, generating efficiencies and improving the quality of care.
NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has several pipeline programs, including a therapeutic device for restless leg syndrome. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.